Back

Incremental value of TAPSE added to HFA-ICOS for ESC-Defined Cancer Therapy–Related Cardiac Dysfunction

28 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Predicting cancer therapy–related cardiac dysfunction: from artificial intelligence-enabled assessment to risk refinement Cardio-Oncology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Nilda Espinola-Zavaleta

National Institute of Cardiology Ignacio Chavez, Mexico City (Mexico)

6 More presentations in this session

Presentation thumbnail
Baseline early diastolic mitral annular velocities and cancer therapy related cardiac dysfunction in HER2 therapy
Mr A. Chowdhury (Clayton, AU)
Abstract Slides
Presentation thumbnail
Incidence and severity of cancer-therapy-related cardiac dysfunction during contemporary breast cancer therapy in a real-world cohort
Doctor V. Vinje (Nordbyhagen, NO)
Abstract Slides Video
Presentation thumbnail
Machine learning-driven probability of cancer therapy–related cardiac dysfunction in patients with non-Hodgkin lymphoma
Doctor D. Bursacovschi (Chisinau, MD)
Abstract Slides
Presentation thumbnail
Agreement between manual and AI-enhanced echocardiographic assessment of cancer therapy-related cardiac dysfunction in patients with early breast cancer
Mr E. Orstad (Nordbyhagen, NO)
Abstract Slides Video
Presentation thumbnail
Cardiopulmonary fitness and cancer therapy-related cardiac dysfunction defined by CMR: insights from the EMBRACE-MRI study
Doctor T. Goncalves (Toronto, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Predicting cancer therapy–related cardiac dysfunction: from artificial intelligence-enabled assessment to risk refinement

The Event

Event poster

ESC Congress 2026

28 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Echocardiographic variables may improve baseline risk prediction of cancer therapy related cardiac dysfunction
1 September 2024
thumbnail
Congress Presentation
Right ventricular to pulmonary artery coupling: an independent marker in a prediction model for heart failure with improved ejection fraction
28 August 2026
thumbnail
Congress Presentation
Effects of sacubitril/valsartan on left and right ventricular function during and after breast cancer therapy: a randomised placebo-controlled trial
29 August 2026
thumbnail
Congress Presentation
Right ventricular free wall strain and tricuspid annular plane systolic excursion for the prediction of left sided cardiotoxicity in lymphoma patients treated with anthracycline-based chemotherapy.
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources